Effect of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors on Lipid Profile and Cardiovascular Events in High-Risk Diabetic Patients.

Cureus · 2025 · PMC12274118 · PMID 40688979

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

The mean LDL-C level decreased markedly from 138.5 ± 17.6 mg/dL at baseline to 64.3 ± 12.9 mg/dL at 12 months, with a t-value of 32.78 (p < 0.001), indicating a highly significant reduction.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.